Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × Tablets × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 8 Polycystic Ovary Syndrome 3 Obesity 2 Neoplasms 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Weight Gain 1 Triple Negative Breast Neoplasms 1 Tracheal Diseases 1 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Salivary Gland Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Overweight 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Multiple Myeloma 1 Mesothelioma 1 Medulloblastoma 1 Lymphoma, Mantle-Cell 1 Lung Neoplasms 1

Interventions

Carboplatin 8 pembrolizumab 6 Radiotherapy 5 Pemetrexed 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Radiation 4 Paclitaxel 3 Nivolumab 3 Cisplatin 3 Biopsy 3 fludarabine phosphate 2 durvalumab 2 aldesleukin 2 Taxes 2 Radiotherapy, Conformal 2 Platinum 2 Ipilimumab 2 Interleukin-2 2 Immunoglobulin G 2 Disulfides 2 Cyclophosphamide 2 CTLA-4 Antigen 2 Bevacizumab 2 1,2-diaminocyclohexaneplatinum II citrate 2 veliparib 1 trametinib 1 sotorasib 1 rucaparib 1 ribociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡